JEFFERSON CITY, Mo. (AP) -- Some are calling it a “game-changer” in the battle against methamphetamine labs a new form of pseudoephedrine that apparently can’t be used to make the dangerous and addictive drug.
The formulation known as Tarex was developed by Highland Pharmaceuticals, a suburban St. Louis company that hopes to have it on the market by summer under the brand name Releva.
Some narcotics officers believe Releva holds promise in turning the tide against meth labs.
A key to meth-making is crystallization. Highland Pharmaceuticals says that rather than crystallizing when heated with chemicals used in meth-making, Tarex results in a gooey substance.
A Missouri House committee on Wednesday heard testimony on a proposal to require a prescription for pseudoephedrine, but it would exempt products that can’t be turned into meth.
(© Copyright 2012 The Associated Press. All Rights Reserved. This material may not be published, broadcast, rewritten or redistributed.)